ZEPZELCA .5 mg/mL
Lurbinectedin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Jazz Pharmaceuticals, Inc.
ZEPZELCA is a injection, powder, lyophilized, for solution containing lurbinectedin at .5 mg/mL, taken intravenous. Manufactured by Jazz Pharmaceuticals, Inc..
Key Facts
- Brand Name
- ZEPZELCA
- Generic Name
- Lurbinectedin
- NDC Code (Product)
68727-712- Manufacturer
- Jazz Pharmaceuticals, Inc.
- Strength
- .5 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA213702
- Drug Class
- Alkylating Drug [EPC]
- Marketing Start
- 06/15/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is ZEPZELCA used for?
ZEPZELCA contains Lurbinectedin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is ZEPZELCA a controlled substance?
ZEPZELCA is not classified as a controlled substance by the DEA.
What is the generic name for ZEPZELCA?
The generic name for ZEPZELCA is Lurbinectedin. There are no other listed brand versions of Lurbinectedin.
What is the NDC code for ZEPZELCA .5 mg/mL?
The NDC (National Drug Code) for ZEPZELCA .5 mg/mL is 68727-712, listed by Jazz Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)